PP
GH icon

PFS Partners’s Guardant Health GH Stock Holding History

PFS Partners’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.5K Hold
330
– – 0.01% 241
2025
Q4 		$33.7K Hold
330
– – 0.02% 221
2025
Q3 		$20.6K Buy
+330
New +$18K 0.01% 266

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PFS Partners's GH Position: Q1 2026 in Review

PFS Partners held its Guardant Health (GH) position steady in Q1 2026 at 330 shares worth $30.5K. The position accounts for 0.01% of the portfolio, ranked #241.

PFS Partners first reported a position in GH in Q3 2025 and has held it in 3 quarters since. The position peaked at $33.7K in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • PFS Partners held 330 shares of Guardant Health worth $30.5K as of Q1 2026.
  • PFS Partners left its Guardant Health share count unchanged in Q1 2026.
  • Guardant Health made up 0.01% of PFS Partners's portfolio in Q1 2026, its #241 holding.
  • PFS Partners first reported a position in Guardant Health in Q3 2025 and has held it in 3 quarters since.
  • PFS Partners's Guardant Health position peaked at $33.7K in Q4 2025.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on PFS Partners's 13F filing for Q1 2026, filed 9 Apr 2026.